Outlook Therapeutics, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Outlook Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • Outlook Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -235 %, a 84.7% decline year-over-year.
  • Outlook Therapeutics, Inc. annual Return On Assets for 2023 was -122 %, a 1.46% increase from 2022.
  • Outlook Therapeutics, Inc. annual Return On Assets for 2022 was -124 %, a 34% increase from 2021.
  • Outlook Therapeutics, Inc. annual Return On Assets for 2021 was -188 %, a 2.06% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -122 +1.81 +1.46% Oct 1, 2022 Sep 30, 2023
2022 -124 +63.9 +34% Oct 1, 2021 Sep 30, 2022
2021 -188 +3.95 +2.06% Oct 1, 2020 Sep 30, 2021
2020 -192 -31.5 -19.6% Oct 1, 2019 Sep 30, 2020
2019 -160 -56.8 -54.9% Oct 1, 2018 Sep 30, 2019
2018 -103 +102 +49.6% Oct 1, 2017 Sep 30, 2018
2017 -205 Oct 1, 2016 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.